united therapeutics uthr

FDA, United Therapeutics and xenotransplantation

FDA approves first xenotransplantation clinical trial, as United Therapeutics forges ahead

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited pigs could provide a viable option for human patients.

Business Insider · 1d

United Therapeutics Says FDA Clears IND For The UKidney Xenotransplantation Clinical Trial

United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has

The Business Journals · 17h

United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the medical community as it is for the business.

21h

United Therapeutics Corporation's (NASDAQ:UTHR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

It is hard to get excited after looking at United Therapeutics' (NASDAQ:UTHR) recent performance, when its stock ...

11hon MSN

United Therapeutics president sells $3.5m in stock

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...

22h

United Therapeutics: TETON 1 study of nebulized Tyvaso for IPF fully enrolled

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...

Yahoo Finance5d

United Therapeutics Corporation (UTHR)

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., January 21, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its ...

Kingswood Wealth Advisors LLC Takes Position in United Therapeutics Co. (NASDAQ:UTHR)

Kingswood Wealth Advisors LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during ...

The Armenian Reporter3d

United Therapeutics (NASDAQ:UTHR) Shares Down 4.9% – What’s Next?

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) shares traded down 4.9% during mid-day trading on Thursday . The stock traded as low as $353.02 and last traded at $354.44. 148,268 shares ...

Yahoo Finance26d

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock

UTHR boasts an average earnings surprise of 4.2%. On a historic basis, United Therapeutics has generated cash flow growth of 10.7%, and is expected to report cash flow expansion of 33.3% this ...

ETF Daily News4d

United Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by Janney Montgomery Scott LLC

Get Our Latest Analysis on United Therapeutics United Therapeutics Price Performance NASDAQ UTHR opened at $351.17 on Friday. United Therapeutics Co. has a 12 month low of $208.62 and a ...

Seeking Alpha5d

UTHR United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results